4//SEC Filing
Herzich Paul 4
Accession 0000950170-24-133317
CIK 0001707502other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:42 PM ET
Size
8.9 KB
Accession
0000950170-24-133317
Insider Transaction Report
Form 4
Herzich Paul
Chief Technology Officer
Transactions
- Sale
Common Stock
2024-12-03$5.60/sh−2,777$15,551→ 12,182 total - Exercise/Conversion
Common Stock
2024-12-02+7,239→ 14,959 total - Exercise/Conversion
Restricted Stock Units
2024-12-02−7,239→ 14,478 total→ Common Stock (7,239 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]Includes 1,698 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024.
- [F3]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Dr. Herzich.
- [F4]The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001954991
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:42 PM ET
- Size
- 8.9 KB